Novartis (SWX:NOVN) Lands Global Radioligand Therapy License To Deepen Cancer Pipeline
Novartis (SWX:NOVN) has signed an exclusive global license agreement with BoomRay Pharmaceuticals for a preclinical radioligand therapy asset.…
Browsing Tag